Craig Chepke, MD

Improved insomnia symptoms with lemborexant treatment may translate into improved daytime functioning.

This study evaluated real-world treatment patterns for patients initiating benztropine and examined treatment approaches in patients with drug-induced movement disorders from a health care provider perspective.

As shown in this review, OSA may be a risk factor for the development of psychiatric conditions, as well as suicidal ideation and attempts.